BioWorld Science

May 25, 2020

View Archived Issues

Optimized benzoxazolone carboxamides for oral treatment of neurological lysosomal storage diseases

Read More

SIRPa blockade wakes up macrophages after infection

Read More

Lasting immunity to SARS-CoV-2 looks possible

Read More

RDIF and ChemRar launch final stage of favipiravir study in patients with COVID-19

Read More

Positive data from outpatient portion of a phase II study of RTU glucagon

Read More

Daiichi Sankyo presents new 5-HT2A receptor agonists

Read More

FDA accepts IND application for phase I/II study of NT-219 in advanced cancer

Read More

Beijing Tide Pharmaceutical patents ROCK2 inhibitors

Read More

Chinese investigators divulge coagulation factor XIa inhibitors

Read More

Roche synthesizes new TLR antagonists

Read More

Fidget spinner allows point-of-care diagnosis of UTIs

Read More

GlaxoSmithKline plc synthesizes new H-PGDS inhibitors

Read More

Phase I/II data presented for LY-500307 in men with schizophrenia

Read More

Serum KL-6 as a biomarker for the management of Mycobacterium avium complex lung disease

Read More

HCP5 is a diagnostic and prognostic marker in AML

Read More

Phase III trial of Dupixent for eosinophilic esophagitis meets coprimary endpoints

Read More

FDA approves Alunbrig for ALK-positive metastatic NSCLC

Read More

FDA approves Phexxi gel to prevent pregnancy

Read More

Phase I/II trial evaluates LS-301 uptake in breast cancer patients

Read More

A new oxime that crosses the blood-brain barrier as a treatment for organo-phosphate poisoning

Read More

Identification of a new peptide targeting the HR1 spike domain as a pan-coronavirus fusion inhibitor

Read More

Kynomycin, a methylated daptomycin analogue, shows promise for multidrug-resistant pathogens

Read More

First clinical data presented for PfSPZ-GA1 antimalarial vaccine

Read More

A human monoclonal antibody neutralizing SARS-CoV-2 and SARS-CoV infections

Read More